Table 1.
Hurdle | Biomarker | References |
---|---|---|
Bloodstream | Complement Activation | [27,28,29,30,31,32,33,34] |
Anti-polymer Antibodies | [40,41,42,43,44,45] | |
Protein Corona/Opsonization | [49,50,51,52,53] | |
Tumor Targeting | Passive Targeting Parameters | [81,82,83,84,85,86,87] |
Active Targeting Parameters | [80,104,105] | |
Tumor Microenvironmental Factors | [113,115,120] | |
Tumor Uptake | [122,123,128] | |
Intracellular Release | Enzyme Levels | [134,141,142] |
pH | [26,153,156,157] | |
Redox Status | [154,155,159,160,161] | |
Additional Hurdles | Gene Mutations | [130] |
Cell Metabolites | [158,175] | |
Age | [55,56,166] | |
Sex | [55,56] | |
Prior PT Treatments | [166] | |
Health/Comorbidities | [12,54] | |
Healthy Tissue Toxicity | [167] | |
Exosomes | [189] |